Challenging the FDA’s authority isn’t new – the agency’s history shows what’s at stake when drug regulation is in limbo

Political pressure is nothing new for the U.S. Food and Drug Administration. The agency has frequently come under fire for its drug approval decisions, but attacks on its decision-making process…

How will the Supreme Court’s decision on mifepristone affect abortion access? 4 questions answered

On April 21, 2023, the U.S. Supreme Court ruled that the abortion pill mifepristone, which is used in more than half of all abortions in the U.S., could remain accessible…

The FDA’s rule change requiring providers to inform women about breast density could lead to a flurry of questions

The U.S. Food and Drug Administration finalized a regulation in early March 2023 that updates mammography reporting requirements. The new regulation goes into effect on Sept. 10, 2024, and will…